tiprankstipranks
Trending News
More News >
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
Japanese Market

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Income Statement

Compare
0 Followers

ASKA Pharmaceutical Holdings Co., Ltd. Income Statement

Last quarter (Q3 2024), ASKA Pharmaceutical Holdings Co., Ltd.'s total revenue was ¥17.55B, an increase of 2.21% from the same quarter last year. In Q3, ASKA Pharmaceutical Holdings Co., Ltd.'s net income was ¥1.54B. See ASKA Pharmaceutical Holdings Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 64.14B¥ 62.84B¥ 60.46B¥ 56.61B¥ 55.18B
Gross Profit
¥ 31.34B¥ 30.66B¥ 28.59B¥ 26.35B¥ 25.38B
Operating Expenses
¥ 26.00B¥ 24.16B¥ 23.48B¥ 21.56B¥ 21.77B
Depreciation and Amortization
¥ 2.25B¥ 2.66B¥ 3.13B¥ 2.88B¥ 3.36B
EBITDA
¥ 8.49B¥ 12.57B¥ 8.24B¥ 7.68B¥ 6.97B
Operating Income
¥ 5.33B¥ 6.50B¥ 5.11B¥ 4.79B¥ 3.61B
Other Income/Expenses
¥ 859.00M¥ 3.36B¥ 249.00M¥ 1.37B¥ -35.00M
Pretax Income
¥ 6.19B¥ 9.86B¥ 5.36B¥ 6.16B¥ 3.58B
Net Income
¥ 5.10B¥ 7.54B¥ 4.24B¥ 4.29B¥ 2.71B
Per Share Metrics
Basic EPS
¥ 179.94¥ 266.49¥ 150.08¥ 151.22¥ 95.63
Diluted EPS
¥ 179.94¥ 266.49¥ 150.08¥ 151.22¥ 95.63
Weighted Average Shares Outstanding
28.35M 28.31M 28.24M 28.37M 28.37M
Weighted Average Shares Outstanding (Diluted)
28.35M 28.31M 28.24M 28.37M 28.37M
Currency in JPY

ASKA Pharmaceutical Holdings Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis